Concepedia
Statistics
Publications
16
Citations
1.3K
H-Index
13
Active since
2002
Affiliations
Scripps Research Institute(Current)
Howard Hughes Medical Institute
Pfizer (United States)
University of Pennsylvania
University of Illinois Chicago
Jonathan W. Lockner is an author at Scripps Research Institute specializing in pharmacology, medicine, and immunology.
Top concepts
MedicinePharmacologyImmunologyDrug DiscoveryVaccinationImmunotherapyMedicinal ChemistryAllergyChemistryAutoimmunity
Publications per year
2002–2020
Discovery of Ketone-Based Covalent Inhibitors of Coronavirus 3CL Proteases for the Potential Therapeutic Treatment of COVID-19
Robert L. Hoffman, Robert S. Kania, Mary A. Brothers et al. · Journal of Medicinal Chemistry · 2020 · 518 citations · Full text
Practical Radical Cyclizations with Arylboronic Acids and Trifluoroborates
Jonathan W. Lockner, Darryl D. Dixon, Rune Risgaard et al. · Organic Letters · 2011 · 186 citations
Arylboronic Acids, Chemical Engineering, Engineering +10
Scalable, Divergent Synthesis of Meroterpenoids via “Borono-sclareolide”
Darryl D. Dixon, Jonathan W. Lockner, Qianghui Zhou et al. · Journal of the American Chemical Society · 2012 · 145 citations
Medicinal Chemistry, Bioorganic Chemistry, Biochemistry +10
Dynamic vaccine blocks relapse to compulsive intake of heroin
Joel E. Schlosburg, Leandro F. Vendruscolo, Paul T. Bremer et al. · Proceedings of the National Academy of Sciences · 2013 · 101 citations · Full text
Small Molecules Targeting Mycobacterium tuberculosis Type II NADH Dehydrogenase Exhibit Antimycobacterial Activity
Michael B. Harbut, Baiyuan Yang, Renhe Liu et al. · Angewandte Chemie International Edition · 2018 · 60 citations
Mycobaterium Tuberculosis, Atp Synthesis, Antimicrobial Chemotherapy +18
1–5 of 16